These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 18806453)

  • 1. Challenges related to cosmetic safety assessment in the EU.
    Rogiers V; Pauwels M
    Curr Probl Dermatol; 2008; 36():29-57. PubMed ID: 18806453
    [No Abstract]   [Full Text] [Related]  

  • 2. Cosmetic products and their current European regulatory framework.
    Rogiers V; Pauwels M
    Curr Probl Dermatol; 2008; 36():1-28. PubMed ID: 18806452
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety evaluation of cosmetics in the EU. Reality and challenges for the toxicologist.
    Pauwels M; Rogiers V
    Toxicol Lett; 2004 Jun; 151(1):7-17. PubMed ID: 15177635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 7th Amendment to the Cosmetics Directive.
    Ruet Rossignol M
    Altern Lab Anim; 2005 Jul; 33 Suppl 1():19-20. PubMed ID: 16194137
    [No Abstract]   [Full Text] [Related]  

  • 5. Is the replacement strategy, as it exists today in the EU for cosmetics, the way forward ?
    Rogiers V
    Arch Toxicol; 2011 May; 85(5):363-4. PubMed ID: 21528384
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of non-animal alternatives in the safety evaluations of cosmetics ingredients by the Scientific Committee on Consumer Safety (SCCS).
    Vinardell MP
    Regul Toxicol Pharmacol; 2015 Mar; 71(2):198-204. PubMed ID: 25555996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical analysis of the safety assessment of cosmetic ingredients performed at the European level.
    Rogiers V; Pauwels M
    Curr Probl Dermatol; 2008; 36():58-93. PubMed ID: 18806454
    [No Abstract]   [Full Text] [Related]  

  • 8. Safety assessment of cosmetic ingredients present in technical information files of finished products.
    Rogiers V; Pauwels M
    Curr Probl Dermatol; 2008; 36():94-114. PubMed ID: 18806455
    [No Abstract]   [Full Text] [Related]  

  • 9. Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010.
    Adler S; Basketter D; Creton S; Pelkonen O; van Benthem J; Zuang V; Andersen KE; Angers-Loustau A; Aptula A; Bal-Price A; Benfenati E; Bernauer U; Bessems J; Bois FY; Boobis A; Brandon E; Bremer S; Broschard T; Casati S; Coecke S; Corvi R; Cronin M; Daston G; Dekant W; Felter S; Grignard E; Gundert-Remy U; Heinonen T; Kimber I; Kleinjans J; Komulainen H; Kreiling R; Kreysa J; Leite SB; Loizou G; Maxwell G; Mazzatorta P; Munn S; Pfuhler S; Phrakonkham P; Piersma A; Poth A; Prieto P; Repetto G; Rogiers V; Schoeters G; Schwarz M; Serafimova R; Tähti H; Testai E; van Delft J; van Loveren H; Vinken M; Worth A; Zaldivar JM
    Arch Toxicol; 2011 May; 85(5):367-485. PubMed ID: 21533817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in European legislation make it timely to introduce a transparent market surveillance system for cosmetics.
    Lodén M; Ungerth L; Serup J
    Acta Derm Venereol; 2007; 87(6):485-92. PubMed ID: 17989885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: eye irritation.
    McNamee P; Hibatallah J; Costabel-Farkas M; Goebel C; Araki D; Dufour E; Hewitt NJ; Jones P; Kirst A; Le Varlet B; Macfarlane M; Marrec-Fairley M; Rowland J; Schellauf F; Scheel J
    Regul Toxicol Pharmacol; 2009 Jul; 54(2):197-209. PubMed ID: 19393279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards an integrated in vitro strategy for repeated dose toxicity testing.
    Vanhaecke T; Pauwels M; Vinken M; Ceelen L; Rogiers V
    Arch Toxicol; 2011 May; 85(5):365-6. PubMed ID: 21512801
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety assessment of cosmetics in Europe. Preface.
    Rogiers V; Pauwels M
    Curr Probl Dermatol; 2008; 36():XVII-XX. PubMed ID: 19177695
    [No Abstract]   [Full Text] [Related]  

  • 14. The cosmetic technical information file in practice.
    Rogiers V; Pauwels M
    Curr Probl Dermatol; 2008; 36():115-28. PubMed ID: 18806456
    [No Abstract]   [Full Text] [Related]  

  • 15. EU borderline cosmetic products review of current regulatory status.
    Morganti P; Paglialunga S
    Clin Dermatol; 2008; 26(4):392-7. PubMed ID: 18691521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: skin irritation.
    Macfarlane M; Jones P; Goebel C; Dufour E; Rowland J; Araki D; Costabel-Farkas M; Hewitt NJ; Hibatallah J; Kirst A; McNamee P; Schellauf F; Scheel J
    Regul Toxicol Pharmacol; 2009 Jul; 54(2):188-96. PubMed ID: 19393278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The critical review of methodologies and approaches to assess the inherent skin sensitization potential (skin allergies) of chemicals. Part III.
    Thyssen JP; Giménez-Arnau E; Lepoittevin JP; Menné T; Boman A; Schnuch A
    Contact Dermatitis; 2012 Apr; 66 Suppl 1():53-70. PubMed ID: 22380842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: genotoxicity. A COLIPA analysis.
    Pfuhler S; Kirst A; Aardema M; Banduhn N; Goebel C; Araki D; Costabel-Farkas M; Dufour E; Fautz R; Harvey J; Hewitt NJ; Hibatallah J; Carmichael P; Macfarlane M; Reisinger K; Rowland J; Schellauf F; Schepky A; Scheel J
    Regul Toxicol Pharmacol; 2010; 57(2-3):315-24. PubMed ID: 20382194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute toxicity.
    Gribaldo L; Gennari A; Blackburn K; Clemedson C; Deguercy A; Meneguz A; Pfaller W; Ruhdel I
    Altern Lab Anim; 2005 Jul; 33 Suppl 1():27-34. PubMed ID: 16194139
    [No Abstract]   [Full Text] [Related]  

  • 20. The critical review of methodologies and approaches to assess the inherent skin sensitization potential (skin allergies) of chemicals. Part II.
    Thyssen JP; Giménez-Arnau E; Lepoittevin JP; Menné T; Boman A; Schnuch A
    Contact Dermatitis; 2012 Apr; 66 Suppl 1():25-52. PubMed ID: 22380841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.